Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | Sep 19, 2024 | 13.42 | +3.31 |
Oak Valley Bancorp | OVLY | Sep 19, 2024 | 28.02 | +6.78 |
Oak Woods Acquisition | OAKU | Sep 19, 2024 | 11.05 | 0.00 |
Oaktree Capital A Pref | OAK-A | Sep 19, 2024 | 24.52 | +0.29 |
Oaktree Capital Group B Pref | OAK-B | Sep 19, 2024 | 23.80 | +0.42 |
Oaktree Specialty | OCSL | Sep 19, 2024 | 16.00 | -0.56 |
Oatly ADR | OTLY | Sep 19, 2024 | 0.93 | -3.12 |
Oblong | OBLG | Sep 19, 2024 | 4.09 | -6.19 |
Occidental Petroleum | OXY | Sep 19, 2024 | 52.03 | +0.54 |
Ocean Biomedical | OCEA | Sep 19, 2024 | 0.99 | +1.28 |
Ocean Power Technologies | OPTT | Sep 19, 2024 | 0.19 | +0.76 |
Oceaneering International | OII | Sep 19, 2024 | 25.86 | +3.40 |
OceanFirst Financial | OCFC | Sep 19, 2024 | 18.91 | +4.30 |
OceanFirst Pref | OCFCP | Sep 19, 2024 | 25.22 | 0.00 |
OceanPal | OP | Sep 19, 2024 | 1.53 | -0.65 |
Ocugen | OCGN | Sep 19, 2024 | 1.14 | +1.79 |
Ocular Therapeutix | OCUL | Sep 19, 2024 | 9.04 | -0.11 |
Oculis | OCS | Sep 19, 2024 | 11.93 | -0.17 |
Ocuphire Pharma | OCUP | Sep 19, 2024 | 1.46 | +9.40 |
Oddity Tech | ODD | Sep 19, 2024 | 36.30 | -0.63 |
Odyssey Marine Exploration | OMEX | Sep 19, 2024 | 1.15 | -18.21 |
Offerpad Solutions A | OPAD | Sep 19, 2024 | 4.59 | +3.15 |
Office Properties | OPI | Sep 19, 2024 | 2.31 | +4.52 |
OFG Bancorp | OFG | Sep 19, 2024 | 45.35 | +1.66 |
OFS Capital | OFS | Sep 19, 2024 | 9.27 | +2.89 |
OFS Credit | OCCI | Sep 19, 2024 | 7.65 | +0.13 |
OFS Credit C Pref | OCCIO | Sep 19, 2024 | 24.35 | -0.52 |
OFS Credit E Pref | OCCIN | Sep 19, 2024 | 23.57 | +0.52 |
OGE Energy | OGE | Sep 19, 2024 | 40.12 | -1.21 |
Ohio Valley Bank | OVBC | Sep 19, 2024 | 24.74 | +0.57 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.